Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza in Children”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07171099
What this trial is testing

Efficacy and Safety of Rengalin in the Treatment of ARVI Cough in Children

Who this might be right for
Cough
Materia Medica Holding 264
Post-approval studies (Phase 4)UnknownNCT06315400
What this trial is testing

Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections

Who this might be right for
Influenza, HumanAcute Respiratory InfectionCommon Cold
Valenta Pharm JSC 80
Not applicableStudy completedNCT04460781
What this trial is testing

Surveillance Study to Assess the Safety of Flublok Quadrivalent (Influenza Vaccine) in Pregnant Women and Their Offspring

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 96,175
Large-scale testing (Phase 3)Study completedNCT00644059
What this trial is testing

Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines

Who this might be right for
Influenza, Human
Novartis 4,902
Testing effectiveness (Phase 2)Study completedNCT00884182
What this trial is testing

Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children

Who this might be right for
InfluenzaOrthomyxoviridae InfectionsOrthomyxovirus Infections
Sanofi Pasteur, a Sanofi Company 350
Testing effectiveness (Phase 2)Study completedNCT00956046
What this trial is testing

Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 401
Large-scale testing (Phase 3)Study completedNCT01051661
What this trial is testing

Safety and Efficacy of H1N1 Vaccines in Children Aged 6 Months to Less Than 10 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 6,154
Large-scale testing (Phase 3)Study completedNCT03445468
What this trial is testing

Immunogenicity and Safety for 'IL-YANG Quadrivalent Influenza Vaccine' in Healthy Korean Children and Adolescents

Who this might be right for
Influenza, Human
Il-Yang Pharm. Co., Ltd. 379
Early research (Phase 1)Study completedNCT01609998
What this trial is testing

Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 75
Post-approval studies (Phase 4)Study completedNCT00412555
What this trial is testing

Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Who this might be right for
Influenza
Hoffmann-La Roche 52
Post-approval studies (Phase 4)Study completedNCT00831675
What this trial is testing

Study of Safety and Immunogenicity of Fluzone® in Healthy Children

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 30
Not applicableStudy completedNCT01146912
What this trial is testing

TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations

Who this might be right for
Influenza
Columbia University 30,537
Post-approval studies (Phase 4)Study completedNCT04551677
What this trial is testing

Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 90
Post-approval studies (Phase 4)Study completedNCT03614975
What this trial is testing

Immunologic Response to Influenza Vaccination in Children and Adolescents

Who this might be right for
Influenza, HumanImmune Response
Richard Zimmerman MD 166
Post-approval studies (Phase 4)Study completedNCT02622659
What this trial is testing

The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)

Who this might be right for
Acute Upper Respiratory Infection
Guangzhou Yipinhong Pharmaceutical CO.,LTD 468
Large-scale testing (Phase 3)Study completedNCT01198756
What this trial is testing

Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children

Who this might be right for
Influenza
GlaxoSmithKline 3,109
Post-approval studies (Phase 4)Ended earlyNCT03020472
What this trial is testing

Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age

Who this might be right for
Influenza
Stanford University 6
Post-approval studies (Phase 4)Study completedNCT00946101
What this trial is testing

Evaluate the Safety of HIN1 Monovalent Vaccine (MEDI3414) in Children 2 to 17 Years of Age

Who this might be right for
Influenza
MedImmune LLC 326